Citations 10

Design of a Phase 2 Study of Suvecaltamide in Moderate-to-severe Parkinson’s Disease Tremor (P9-3.009)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206381

Effects of ADS-5102 on non-motor symptoms (NMS) in Parkinson’s disease patients with dyskinesia (P1.039)

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p1.039

Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease

Annals of Internal Medicine | November 7, 2022 | Volume: 175 | Issue: 12 | Pages: 1666-1674

10.7326/m22-1438 | PMID 36343348

Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary

Neurology | November 15, 2021 | Volume: 97 | Issue: 20 | Pages: 942-957

10.1212/wnl.0000000000012868 | PMID 34782410

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression

JAMA | September 14, 2021 | Volume: 326 | Issue: 10 | Pages: 926

10.1001/jama.2021.10207 | PMID 34519802

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS)

JAMA Neurology | November 16, 2015 | Volume: 73 | Issue: 1 | Pages: 102

10.1001/jamaneurol.2015.2736 | PMID 26569098

A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

JAMA Neurology | March 25, 2014 | Volume: 71 | Issue: 5 | Pages: 543

10.1001/jamaneurol.2014.131 | PMID 24664227

Ropinirole for restless legs syndrome

Neurology | May 13, 2012 | Volume: 62 | Issue: 8 | Pages: 1405-1407

10.1212/01.wnl.0000120672.94060.f1 | PMID 15111683

Ropinirole for the treatment of early Parkinson's disease

Neurology | May 13, 2012 | Volume: 49 | Issue: 2 | Pages: 393-399

10.1212/wnl.49.2.393 | PMID 9270567

Activity enhances dopaminergic long-duration response in Parkinson disease

Neurology | March 30, 2012 | Volume: 78 | Issue: 15 | Pages: 1146-1149

10.1212/wnl.0b013e31824f8056 | PMID 22459675